Mass Device Fast Five: Aug 16, 2023

The episode covers FDA authorization for Viz.ai’s artificial intelligence-based module for detecting hypertrophic cardiomyopathy. The FDA’s de novo nod creates a new regulatory category for cardiovascular machine learning-based notification software. Learn about how this module works as this AI-based technology garners regulatory approval.